Search research articles
Contact Us
Filters
Showing results (121-130 of 186) with videos related to
Page
of 19
Sort By:
The American Journal of Gastroenterology
|
December 1, 1995
Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis
B J Zins, W J Sandborn, C R Penna, et al.
Alimentary Pharmacology & Therapeutics
|
December 14, 1999
A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis
L J Egan, W J Sandborn, W J Tremaine, et al.
Alimentary Pharmacology & Therapeutics
|
November 14, 1997
Nicotine enemas for active ulcerative colitis--a pilot study
J T Green, G A Thomas, J Rhodes, et al.
The Journal of Biological Chemistry
|
September 3, 1999
Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity
L J Egan, D C Mays, C J Huntoon, et al.
The American Journal of Gastroenterology
|
July 14, 2000
Early measles virus infection is associated with the development of inflammatory bowel disease
D S Pardi, W J Tremaine, W J Sandborn, et al.
Gastroenterology
|
June 1, 1994
A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis
W J Sandborn, W J Tremaine, K W Schroeder, et al.
Alimentary Pharmacology & Therapeutics
|
September 19, 2015
Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis
B Jharap, W J Sandborn, W Reinisch, et al.
Alimentary Pharmacology & Therapeutics
|
March 20, 2010
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
R Panaccione, J-F Colombel, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics
|
May 22, 2015
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
M Rosario, N L Dirks, M R Gastonguay, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1997
Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis
J T Green, G A Thomas, J Rhodes, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 186) with videos related to
Sort By:
Page
of 19
The American Journal of Gastroenterology
|
December 1, 1995
Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis
B J Zins, W J Sandborn, C R Penna, et al.
Alimentary Pharmacology & Therapeutics
|
December 14, 1999
A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis
L J Egan, W J Sandborn, W J Tremaine, et al.
Alimentary Pharmacology & Therapeutics
|
November 14, 1997
Nicotine enemas for active ulcerative colitis--a pilot study
J T Green, G A Thomas, J Rhodes, et al.
The Journal of Biological Chemistry
|
September 3, 1999
Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity
L J Egan, D C Mays, C J Huntoon, et al.
The American Journal of Gastroenterology
|
July 14, 2000
Early measles virus infection is associated with the development of inflammatory bowel disease
D S Pardi, W J Tremaine, W J Sandborn, et al.
Gastroenterology
|
June 1, 1994
A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis
W J Sandborn, W J Tremaine, K W Schroeder, et al.
Alimentary Pharmacology & Therapeutics
|
September 19, 2015
Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis
B Jharap, W J Sandborn, W Reinisch, et al.
Alimentary Pharmacology & Therapeutics
|
March 20, 2010
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
R Panaccione, J-F Colombel, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics
|
May 22, 2015
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
M Rosario, N L Dirks, M R Gastonguay, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1997
Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis
J T Green, G A Thomas, J Rhodes, et al.
Page
of 19